Skip to content

Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects

Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00315965
Enrollment
107
Registered
2006-04-19
Start date
2006-07-31
Completion date
2007-09-30
Last updated
2007-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Diffusing Capacity

Keywords

Diffusion, Membrane diffusing capacity, Alveolar capillary gas diffusion, Transfer factor, Nitric oxide diffusion

Brief summary

Using a rapidly responding nitric oxide analyzer in a new developed modular lung-function-setup we are going to measure steady-state NO diffusing capacity in 107 healthy subjects (age 6-45 years). The results will be compared to those measured by using carbon monoxide single-breath estimates. We like to show that the new method is sufficient to measure exactly lung diffusion capacity in this collective.

Interventions

DRUGNitric oxide, Carbon monoxide, Helium

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers * Lung function testing possible * Written consent

Exclusion criteria

* Pulmonary, neuromuscular, cardiovascular, endocrinological illness * Pregnancy * Abuse of nicotine, alcohol, drugs during the last two years

Design outcomes

Primary

MeasureTime frame
TLNOss
TLCOsb

Secondary

MeasureTime frame
functional residual capacity
airway resistance
lung clearance index
Breathing frequency
vital capacity
total lung capacity
forced expiratory volume in one second
tidal volume

Countries

Germany

Contacts

Primary ContactTobias Pantalitschka, MD
tobias.pantalitschka@med.uni-tuebingen.de+49 70712984711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026